Company Performance Metrics
- Elena Aster: CEO
F1 Biosciences is a UAE-based biotech platform building biological continuity infrastructure: viable cell preservation, cloning, genetic biobanking, and animal-model systems for longevity translation.
The GCC is building genomic intelligence and precision-health platforms. Most current infrastructure is optimised to read biology — not to preserve,
control, and reactivate it. F1 Biosciences builds that missing layer.
At the core of our longevity platform is the animal-to-human bridge: studying negligible senescence species — naked mole rat, bowhead whale, long-lived reptiles — to understand what biology looks like when aging is no longer inevitable. Combined with SCNT-derived epigenetic reprogramming and organoid-based research systems, we translate extreme animal biology into the foundations of human longevity medicine.
PLATFORM · Cloning-Ready Cell Banking — end-to-end chain from biopsy to reproductive readiness · Genetic Biopreservation — 2,000+ samples, 200+ species, UAE's largest multi-species biobank · Reproductive Biotechnology — SCNT, assisted reproduction, interspecies embryo technologies · Animal-Model Systems — controlled biological baselines for longevity research and translational validation
DE-EXTINCTION PROGRAMS · Arabian Leopard · Woolly Mammoth (with Colossal Biosciences) · Emirati Leaf-toed Gecko · Arabian Tahr
4 peer-reviewed publications · Collaboration with Colossal Biosciences & Revive & Restore Aligned with Abu Dhabi's ambition for sovereign biotech, longevity, and precision health.
f1biosciences.com
